Nowotwory złośliwe w Polsce w 2017 roku http://onkologia.org.pl/wp-content/uploads/Nowotwory_2017.pdf
Kantor AF, Hartge P, Hoover RN, Fraumeni JF Jr. Familial and environmental interactions in bladder cancer risk. Int J Cancer. 1985;35(6):703–6. https://doi.org/10.1002/ijc.2910350602.
CAS Article PubMed Google Scholar
Hasumi H, Yao M. Hereditary kidney cancer syndromes: Genetic disorders driven by alterations in metabolism and epigenome regulation. Cancer Sci. 2018;109(3):581–6. https://doi.org/10.1111/cas.13503 Epub 2018 Feb 15.
CAS Article PubMed PubMed Central Google Scholar
Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004;95(11):866–71. https://doi.org/10.1111/j.1349-7006.2004.tb02195.x.
CAS Article PubMed PubMed Central Google Scholar
Easton DF, Bishop DT, Fordd D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet. 1993;52(4):678–701.
CAS PubMed PubMed Central Google Scholar
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994;343(8899):692–5.
Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet. 2005;42(7):602–3. https://doi.org/10.1136/jmg.2004.024133.
CAS Article PubMed PubMed Central Google Scholar
Couch FJ, Farid LM, Deshano ML, Tavtigian SV, Calzone K, Campeau L, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet. 1996;13(1):123–5. https://doi.org/10.1038/ng0596-123.
CAS Article PubMed Google Scholar
Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62(3):676–89. https://doi.org/10.1086/301749.
CAS Article PubMed PubMed Central Google Scholar
Cybulski C, Górski B, Gronwald J, Huzarski T, Byrski T, Dębniak T, et al. BRCA1 mutations and prostate cancer in Poland. Eur J Cancer Prev. 2008;17(1):62–6. https://doi.org/10.1097/CEJ.0b013e32809b4d20.
CAS Article PubMed Google Scholar
Dębniak T, Scott RJ, Górski B, Cybulski C, van de Wetering T, Serrano-Fernandez P, et al. Common variants of DNA repair genes and malignant melanoma. Eur J Cancer. 2008;44(1):110–4. https://doi.org/10.1016/j.ejca.2007.10.006.
CAS Article PubMed Google Scholar
Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer. 2004;110(5):683–6.
Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM, Bansal R, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 2002;62(13):3789–93.
Sweis RF, Heiss B, Segal J, Ritterhouse L, Kadri S, Churpek JE, et al. Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations. JCO Precis Oncol. 2018;2(2):1–7. https://doi.org/10.1200/PO.18.00264.
Nassar AH, Abou Alaiwi S, AlDubayan SH, Moore N, Mouw KW, Kwiatkowski DJ, et al. Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma. Genet Med. 2020;22(4):709–18. https://doi.org/10.1038/s41436-019-0720-x Epub 2019 Dec 17.
CAS Article PubMed Google Scholar
Mouw KW. DNA repair pathway alterations in bladder Cancer. Cancers (Basel). 2017;9(4):28. https://doi.org/10.3390/cancers9040028.
Górski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, et al. Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat. 2005;92(1):19–24. https://doi.org/10.1007/s10549-005-1409-1.
Górski B, Narod SA, Lubinski J. A common missense variant in BRCA2 predisposes to early onset breast cancer. Breast Cancer Res. 2005;7(6):R1023–7. https://doi.org/10.1186/bcr1338 Epub 2005 Oct 24.
CAS Article PubMed PubMed Central Google Scholar
Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, et al. Founder mutations in the BRCA1 gene in polish families with breast-ovarian cancer. Am J Hum Genet. 2000;66(6):1963–8. https://doi.org/10.1086/302922.
Article PubMed PubMed Central Google Scholar
Lubiński J, Korzen M, Górski B, Cybulski C, Dębniak T, Jakubowska A, et al. Breast cancer susceptibility genes. J BUON. 2007;12:23–9.
Lubiński J, Korzeń M, Górski B, Cybulski C, Dębniak T, Jakubowska A, et al. Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology. Breast Cancer Res Treat. 2009;114(1):121–6. https://doi.org/10.1007/s10549-008-9974-8 Epub 2008 Apr 15.
Lewandowska M, Sajdak S, Marciniak W, Lubiński J. First Trimester Serum Copper or Zinc Levels, and Risk of Pregnancy-Induced Hypertension. Nutrients. 2019;11(10):2479.
Lichtenstein R, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85.
Gronwald J, Huzarski T, Byrski B, Medrek K, Menkiszak J, Monteiro AN, et al. Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status. J Med Genet. 2006;43(5):424–8. https://doi.org/10.1136/jmg.2005.036921 Epub 2005 Oct 14.
CAS Article PubMed Google Scholar
Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD, Kim-Sing C, et al. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. J Natl Cancer Inst. 2010;102(24):1874–8. Epub 2010 Nov 23. https://doi.org/10.1093/jnci/djq443.
CAS Article PubMed Google Scholar
Lubinski J, Huzarski T, Byrski T, Lynch HT, Cybulski C, Ghadirian P, et al. The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Hereditary breast Cancer clinical study group. Int J Cancer. 2012;131(1):229–34. https://doi.org/10.1002/ijc.26369.
CAS Article PubMed Google Scholar
Jakubowska A, Nej K, Huzarski T, Scott RJ, Lubiński J. BRCA2 gene mutations in families with aggregations of breast and stomach cancers. Br J Cancer. 2002;87(8):888–91.
Jakubowska A, Scott R, Menkiszak J, Gronwald J, Byrski T, Huzarski T, et al. A high frequency of BRCA2 gene mutations in polish families with ovarian and stomach cancer. Eur J Hum Genet. 2003;11(12):955–8. https://doi.org/10.1038/sj.ejhg.5201064.
CAS Article PubMed Google Scholar
Kwiatkowska E, Teresiak M, Lamperska KM, Karczewska A, Breborowicz D, Stawicka M, et al. BRCA2 germline mutations in male breast cancer patients in the Polish population. Hum Mutat. 2001;17(1):73. https://doi.org/10.1002/1098-1004(2001)17:1<73::AID-HUMU12>3.0.CO;2-O.
CAS Article PubMed Google Scholar
Na R, Wu Y, Jiang G, Yu H, Lin X, Wang M, et al. Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis. BJU Int. 2018;122(5):808–13. https://doi.org/10.1111/bju.14370.
留言 (0)